Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472791 | 12647279 | 1 | I | 20160730 | 20160812 | 20160812 | EXP | US-LUPIN PHARMACEUTICALS INC.-2016-03510 | LUPIN | HYLAND K, WEBER T. UNRECOGNIZED MILK-ALKALI SYNDROME WITH HYPOCALCEMIA FOLLOWING BISPHOSPHONATE TREATMENT. ENDOCRINE REVIEWS. 2014;. | 41.00 | YR | F | Y | 0.00000 | 20160812 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126472791 | 12647279 | 1 | PS | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Unknown | UNKNOWN | 202127 | ||||||||||
| 126472791 | 12647279 | 2 | SS | Esomeprazole | ESOMEPRAZOLE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126472791 | 12647279 | 3 | SS | Zoledronic acid | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG | UNKNOWN | 0 | |||||||||
| 126472791 | 12647279 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | |||||||||||
| 126472791 | 12647279 | 5 | C | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 0 | |||||||||||
| 126472791 | 12647279 | 6 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 0 | |||||||||||
| 126472791 | 12647279 | 7 | C | Timethoprim/Sulfamethoxazole | 2 | Unknown | 0 | ||||||||||||
| 126472791 | 12647279 | 8 | C | GANCICLOVIR. | GANCICLOVIR | 1 | Unknown | 0 | |||||||||||
| 126472791 | 12647279 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 0 | Q6H | ||||||||||
| 126472791 | 12647279 | 10 | C | Calcitonin | CALCITONIN | 1 | Oral | 200 MICROGRAM | 0 | Q6H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126472791 | 12647279 | 1 | Product used for unknown indication |
| 126472791 | 12647279 | 2 | Gastrooesophageal reflux disease |
| 126472791 | 12647279 | 3 | Product used for unknown indication |
| 126472791 | 12647279 | 4 | Product used for unknown indication |
| 126472791 | 12647279 | 5 | Product used for unknown indication |
| 126472791 | 12647279 | 6 | Product used for unknown indication |
| 126472791 | 12647279 | 7 | Product used for unknown indication |
| 126472791 | 12647279 | 8 | Product used for unknown indication |
| 126472791 | 12647279 | 9 | Product used for unknown indication |
| 126472791 | 12647279 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126472791 | 12647279 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126472791 | 12647279 | Hypocalcaemia | |
| 126472791 | 12647279 | Milk-alkali syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |